Mirati Therapeutics Inc (NASDAQ: MRTX), a clinical-stage targeted oncology company, has named Jenny Gizzi as its new vice president, Human Resources, it was reported yesterday.
Gizzi will report directly to Charles M Baum, MD, PhD, president and chief executive officer. In her role, she will be responsible for all aspects of the company's human resources operations and strategy, including managing the planning, development, implementation and administration of Mirati's human resources programs. She will also be responsible for long range human resources planning to assist Mirati with continued growth.
Gizzi joins Mirati Therapeutics with more than 20 years of experience in human resources, most recently serving as the head of Strategy & Operations, Business Insights and Analytics at Bristol-Myers Squibb. Earlier in her career at Bristol-Myers Squibb, Gizzi served as head of Human Resources for the Bay Area and Cambridge, and head of Global Talent for European Markets, Australia and Canada where her responsibilities included heading global talent for eight markets and 13 countries and leading the international team specialising in creation of overall talent strategy. Prior to her time at Bristol-Myers Squibb, she was head of Global Talent Acquisition for Illumina Inc where she was ultimately responsible for their talent function globally.
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees